NIH-funded research NIH-funded research

Improving cancer treatment with radiation therapy

Official title: Core C: Radiosensitization Core

Funded at University of Michigan at Ann Arbor · NIH-10917041 · Data updated 2026-11-12

This study is looking at ways to make radiation therapy work better for cancer patients by testing different treatments that can help tumors respond more effectively to the radiation.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startAugust 14, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$114,186
NIH project number5P50CA269022-02
Project IDNIH-10917041 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with specific types of cancer who are undergoing or considering radiation therapy as part of their treatment plan.

Less likely to help

Patients with non-cancerous conditions or those not receiving radiation therapy may not benefit from this research.

What this research studies

This research focuses on enhancing the effectiveness of radiation therapy for cancer by evaluating how different therapeutic agents can sensitize tumors to radiation. The team will use advanced techniques to irradiate cultured cells and animal models, developing precise treatment plans for targeting tumors. By utilizing imaging technologies, they aim to optimize the combination of therapies to improve patient outcomes. The project also involves collaboration with various resources at the Rogel Cancer Center to ensure comprehensive support for the research activities.

Why it matters

Potential benefit: If successful, this research could lead to more effective cancer treatments that improve survival rates and reduce side effects for patients undergoing radiation therapy.

How similar studies have gone: Previous research has shown promising results in enhancing radiation therapy effectiveness through sensitization strategies, indicating a strong potential for success in this approach.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Rehemtulla, Alnawaz — University of Michigan at Ann Arbor
  • Study coordinator: Rehemtulla, Alnawaz

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.